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Simultaneous Quantification of Bone Edema/Adiposity
and Structure in Inflamed Bone Using Chemical
Shift-Encoded MRI in Spondyloarthritis
Timothy J.P. Bray,1,3* Alan Bainbridge,2 Shonit Punwani,1 Yiannis Ioannou,3 and
Margaret A. Hall-Craggs1*
Purpose: To evaluate proton density fat fraction (PDFF) and
R2* as markers of bone marrow composition and structure in
inflamed bone in patients with spondyloarthritis.
Methods: Phantoms containing fat, water, and trabecular bone
were constructed with proton density fat fraction (PDFF) and
bone mineral density (BMD) values matching those expected in
healthy bone marrow and disease states, and scanned using
chemical shift-encoded MRI (CSE-MRI) at 3T. Measured PDFF
and R2* values in phantoms were compared with reference FF
and BMD values. Eight spondyloarthritis patients and 10 con-
trols underwent CSE-MRI of the sacroiliac joints. PDFF and R2*
in areas of inflamed bone and fat metaplasia in patients were
compared with normal bone marrow in controls.
Results: In phantoms, PDFF measurements were accurate
over the full range of PDFF and BMD values. R2* measure-
ments were positively associated with BMD but also were
influenced by variations in PDFF. In patients, PDFF was
reduced in areas of inflammation and increased in fat metapla-
sia compared to normal marrow. R2* measurements were sig-
nificantly reduced in areas of fat metaplasia.
Conclusion: PDFF measurements reflect changes in marrow
composition in areas of active inflammation and structural
damage and could be used for disease monitoring in spondy-
loarthritis. R2* measurements may provide additional information
bone mineral density but also are influenced by fat content.
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INTRODUCTION
The spondyloarthritides are a group of inflammatory dis-
eases involving the spine, lower limb joints, and enthe-
ses (1). Clinical features of spondyloarthritis include
back pain, spinal stiffness and loss of mobility, which
may be caused by inflammation, structural damage, or a
combination of both (2,3). Inflammation usually occurs
in the form of spondylitis, spondylodiscitis, or spondy-
loarthritis. Sacroiliac joint inflammation—sacroiliitis—is
a common feature. Structural manifestations include syn-
desmophyte formation and joint fusion, which are
thought to be caused by chronic inflammation and subse-
quent new bone formation (1). However, bone destruc-
tion also occurs commonly and patients may suffer from
generalized osteoporosis and increased fracture risk
(4–6). Spondyloarthritis usually affects young people;
patients often present in their 20s (1). An early age at
disease onset is associated with a worse functional out-
come (7). Patients presenting in childhood or adoles-
cence have a particularly poor prognosis (8).
In recent years, there has been a move toward early
identification and treatment of spondyloarthritis in an
attempt to improve long-term functional outcomes (9).
Although biologic therapy has been shown to be effective
at reducing the burden of inflammation, clinical assess-
ment of response can be difficult, and it may be unclear
if inflammation is adequately controlled (9). Further-
more, many patients undergo structural progression (par-
ticularly joint fusion) despite biologic therapy (10). As a
result, MRI increasingly is used to monitor inflammation
and structural damage (11,12) and to facilitate therapeu-
tic decision making (9,13). Current clinical imaging pro-
tocols mainly rely on conventional spin echo sequences:
fat-suppressed T2-weighted images are used to detect
active inflammation (active inflammation causes an
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increase in bone marrow water content), whereas T1-
weighted images are used to evaluate structural features,
including fat metaplasia (defined as an increase in bone
marrow fat content that typically occurs in areas of pre-
vious inflammation) and joint fusion (14). However,
existing imaging techniques have multiple limitations.
First, despite the fact that new bone formation and bone
destruction both are key features of spondyloarthritis (4),
spin echo sequences provide minimal information about
trabecular structure or density. Arguably, this has contrib-
uted to the uncertainty around the nature of structural
changes in the joint and adjacent bone marrow in chronic
sacroiliitis (12,15). For example, it has been argued that fat
metaplasia is an intermediate stage in the bone-forming
pathway (15), but there are no existing data on whether
trabecular bone density is altered in these areas. Similarly,
it has been argued that the appearance of T1-hyperintense
tissue in the joint itself (backfill) is an indicator of new
bone formation (15), but no measurements of bone mineral
density have been performed in these areas.
Second, image assessment relies on visual comparison
of differences in image intensity after acquisition by a
radiologist or rheumatologist. This method is highly sub-
jective and relies on multiple sequences, none of which
are entirely specific for inflammation. For example, the
quality of fat suppression using the short tau inversion
recovery (STIR) sequence is critical for assessment of
active inflammation, but in our experience this is variable
and often suboptimal. In addition, scoring systems
involve binary choices as to whether inflammation is pre-
sent in a given joint quadrant, and further binary choices
regarding the depth and intensity of inflammation (11).
Assessment of edema intensity requires a somewhat arbi-
trary comparison with the brightness of presacral blood
vessels (11), and therefore is dependent on the sequence
parameters and the scanning platform. Accordingly, agree-
ment between observers’ assessment of inflammation is
suboptimal even in a controlled research setting at a sin-
gle site (16,17), and could be poorer still in clinical prac-
tice. Finally, spin echo-based methods are relatively slow,
which makes them less well suited to whole body imag-
ing. Whole body imaging may be useful for identifying
occult joint inflammation (18,19), but using STIR sequen-
ces is time-consuming and therefore impractical for
patients with stiff and painful joints.
As a result of these limitations, there is an unmet need
for quantitative physical measurements of bone marrow
characteristics in patients with spondyloarthritis. Chemi-
cal shift-encoded MRI (CSE-MRI) (20) can accurately
measure bone marrow composition in terms of proton
density fat fraction (PDFF) (21), and therefore could be
used to assess marrow composition. Furthermore, the
presence of trabeculae in cancellous bone increases the
rate of signal decay R2* because bony trabeculae are
more diamagnetic than the surrounding marrow (22).
Thus, R2* may be regarded as a marker of trabecular
bone mineral density (BMD). The rate of signal loss R2*
is thought to be related to trabecular BMD in an approxi-
mately linear fashion (23,24). However, R2* measure-
ments may be biased by variations in fat content (25),
and if unaccounted for, R2* decay may also confound
the measurement of fat content (26).
In this study, we evaluated PDFF and R2* measure-
ments as potential markers of bone marrow composition
and structure in inflamed juxta-articular bone. To assess
the relationship between BMD and R2* in the presence
of fat, and between known FFs and PDFF measurements
in the presence of bone, we constructed a series of phan-
toms containing varying proportions of fat, water, and
trabecular bone and then imaged these phantoms using
CSE-MRI. In vivo, we performed CSE-MRI in the sacroil-
iac joints of patients with spondyloarthritis and exam-
ined whether there were significant differences in PDFF
and R2* between areas of active inflammation, fat meta-
plasia, and normal marrow.
THEORY
Using a gradient-echo based CSE-MRI acquisition, the
signal S(tn) acquired at the nth echo time tn can be
written:
SðtnÞ5 qW1qF
XM
m51
rmexpði2pfF ;mtnÞ
 !
expði2pfBtnÞexpð2tnR2Þ
where qW and qF are the amplitudes of water and fat
components; fF,m is the frequency of each spectral fat
component; rm is the relative amplitude of each spectral
fat component; M is the total number of fat components;
and R2*¼R2þR20, where R2 and R20 are the rate con-
stants for irreversible and reversible spin dephasing,
respectively. In cancellous bone, the presence of trabecu-
lae predominantly increases R20 (22), although R2 also
may be increased due to diffusion of protons in gradients
generated by susceptibility differences (22,23). Previous
studies suggest that the relationship between marrow
BMD and R2* is approximately linear (23,24). The pres-
ence of fat and noise can both potentially confound R2*
measurements, although the use of a multipeak spectral
fat model can help reduce this bias (25,27).
For the purposes of fat quantification, R2* can be
assumed to be equal for all fat and water components
(26,28) or can be modelled separately for fat and water.
Although using separate R2* decay terms for water and
fat is feasible in trabecular bone (29), it has been argued
that the use of a single ‘system’ R2* term is more practi-
cal and results in greater robustness to noise, and also
may be particularly suitable in short-T2* environments
(30). Previous phantom studies suggest that marrow fat
quantification using a single R2* term is accurate (21).
For these reasons, we have opted against using dual R2*
terms in this work and have instead assumed a single
marrow-system R2*.
METHODS
This study received ethical approval from the Queen
Square Research Ethics Committee, London, United
Kingdom (Research Ethics Committee reference 15/LO/
1475). All participants gave written informed consent
prior to study entry.
Fat–Water Phantom
A fat–water phantom consisting of twelve 50-mL centri-
fuge tubes with varying true fat volume percentages was
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constructed based on phantoms previously described
(31,32), with fat percentages chosen to reflect the range of
FF values observed in both normal and pathological bone
marrow. True fat volume percentages in the phantom were
0, 10, 20, 30, 40, 45, 50, 55, 60, 65, 70, and 100%. Peanut
oil was used as a surrogate for human fat because its NMR
spectrum is similar to that of human adipose tissue (26,33)
and comprises approximately 9% palmitic, 4% stearic,
55% oleic, and 27% linoleic acids (34). In this work, we
adopt the approach of Gee et al. (21) and use fat volume
percentages as reference FFs. For each tube, the appropri-
ate volume of peanut oil was dispensed by weight, assum-
ing the density of peanut oil (0.916 g/cm3). Sodium
dodecyl sulphate (SDS) (surfactant; Sigma-Aldrich, St.
Louis, Missouri, USA) was added to the peanut oil and
gently mixed to form an initial emulsion, ensuring a final
SDS concentration in each phantom of 28mM. Appropri-
ate volumes of 3.0% weight/volume agar solution pre-
heated to 90 C were then added to each tube, and each
tube was mixed by gentle inversion for approximately 2
minutes. The tubes cooled at room temperature, and all
formed a solid gel (with the exception of the 100% FF
tube, which contained pure oil).
Photographs of the 0%, 40% and 70% FF tubes from
the fat–water phantom are shown in Figure 1a; micro-
scopic images of a drop of the fresh emulsion (Zeiss
LSM 710 confocal microscope; Carl Zeiss, Oberkochen,
Germany) are shown in Figure 1b.
Fat–Water–Bone Phantom
The fat–water–bone phantom consisted of fat–water mix-
tures with the addition of granules of decellularized
bovine bone matrix (NuOss granules, particle size 250–
1,000mm, Henry Schein, London, UK), which are physi-
cally and chemically similar to the mineral matrix of
human bone and retain their natural trabecular structure.
The mass of bone matrix in the tubes was chosen to
reflect the range of trabecular bone mineral density values
occurring in healthy subjects (35) and disease states (BMD
values were 0, 50, 100, and 150mg/cm3). Phantoms were
constructed in 5mL scintillation vials. To ensure homoge-
neity, the bone granules were first thoroughly mixed with
oil before sequential addition of SDS and heated agar.
Final mixtures of fat, bone, and agar were then continu-
ally agitated with a high-speed touch-mixer (Vortex-Genie
2, Cole-Parmer, London, UK) until solid. Again, all tubes
FIG. 1. Fat–water (a, b) and fat–water–bone (c, d) phantoms. (a) 0%, 30%, and 70% FF vials are shown lying flat to demonstrate solid-
ity. (b) Microscopic images of 50% FF tube shows the arrangement of fat and water in the emulsion (the fat globules are circular and
outlined by dark lines). (c) Photograph of the fat–water–bone phantom, showing fat content varying by row and bone mineral density
varying by column. (d) Microscopic images of trabecular bone granules in dilute emulsion (approximately 10% FF); a number of fat
droplets are visible coating the surface of the trabeculae. FF, fat fraction.
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formed a solid gel. The volume of the bone granules was
much smaller than the volume of fluid in each vial (i.e.,
unmeasurable); the volume of the bone granules therefore
was neglected in calculations of BMD.
The arrangement of the fat–water–bone phantom is
shown in Figure 1c; microscopic images of fat–water
emulsions containing trabecular bone are shown in Fig-
ure 1d.
Patients and Volunteers
Subjects were prospectively recruited by rheumatologists
working in a specialist tertiary rheumatology clinic.
Patients aged between 12 and 30 years were included in
the study if they had a known diagnosis of sacroiliitis
(diagnosed previously on MRI) or were suspected of
having sacroiliitis after assessment by a rheumatologist.
All patients with sacroiliitis fulfilled diagnostic criteria
for enthesitis-related arthritis (with axial involvement) or
nonradiographic axial spondyloarthritis (36–38). Patients
with suspected sacroiliitis at the time of the scan were
subsequently treated as controls if the clinical MRI scan
and clinical assessment were normal. In addition, eight
healthy volunteers aged between 18 and 30 years had
repeat MRI scans of the sacroiliac joints 1 month apart to
assess measurement repeatability.
Imaging Sequence and Reconstruction
CSE-MRI of phantoms and all subjects was performed on a
wide-bore 3.0T clinical system (Ingenia, Philips, Amster-
dam, Netherlands), with integrated posterior and anterior
surface coils using a 3D spoiled gradient echo recalled
acquisition. Images of patients and volunteers were
acquired in a tilted coronal plane parallel to the long axis of
the sacrum, and 40 slices were acquired with a slice thick-
ness of 2mm. Imaging was performed using a vendor-
supplied gradient echo sequence (Philips mDixon Quant;
Philips Healthcare, Andover, Massachusetts, USA), which
acquires six evenly-spaced echoes (first echo time 1.17 ms,
echo spacing 1.6 ms) using bipolar readout gradients
(39–41). PDFF and R2* maps were generated inline, assum-
ing a 10-peak model of human adipose tissue, as previously
described (40,42). Other sequences parameters included:
time to repetition (TR) 25 ms, flip angle 3 , matrix size
320 320, pixel spacing 1.76mm1.76mm, and pixel
bandwidth 394Hz/Px. Parallel imaging was not used. Addi-
tionally, all patients underwent a standard clinical MRI
scan on the same day on a 1.5T system (Avanto, Siemens,
Berlin, Germany) with coronal T1-weighted and T2-
weighted STIR sequences (14), which were acquired in the
same tilted coronal plane as the CSE scans.
Statistical Analysis
For the phantom experiments, statistical analyses were
based on those used in previous phantom studies using
fat–water phantoms (26). PDFF and R2* measurements
were performed using circular regions-of-interest (ROIs)
placed on axial slices through the phantom tubes, taking
care to avoid the edges of the emulsions. ROIs were placed
in identical locations on PDFF and R2* maps. To assess
the accuracy of FF measurements, linear regression was
performed between known and measured FFs, and two-
sided t tests were used to determine whether there were
statistically significant differences between obtained slope
values and 1.0, and obtained intercept values and 0.0
(/¼0.05). To assess the relationship between BMD and
R2*, linear regression was performed between measured
R2* values and known BMD values, and analysis of
FIG. 2. Delineation of edema and fat metaplasia. Areas of bone marrow edema and fat metaplasia were identified on T2-weighted STIR
(a) and T1-weighted (d) spin echo images, respectively. Freehand regions of interest were placed on these images (b, e) and directly
transferred to the corresponding anatomical location on PDFF maps (c, f) using the sacroiliac joints and sacral foraminae as anatomical
landmarks. PDFF, proton density fat fraction; STIR, short tau inversion recovery.
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covariance was used to determine whether obtained slope
and intercept values were significantly different in vials
containing fat compared to 0% fat-fraction vials.
For the patient study, areas of bone marrow edema
and/or fat metaplasia in patients with sacroiliitis were
identified on T2-weighted STIR and T1-weighted images,
respectively, and freehand ROIs were placed on those
areas—taking care to avoid normal bone—by a radiology
registrar (T.J.P.B.) with 4 years of experience in musculo-
skeletal MRI (see Fig. 2). A maximum of four ROIs for
bone marrow edema and four ROIs for fat metaplasia
were used in each subject. Using the synovial and liga-
mentous portions of the sacroiliac joints and sacral
foramina as fixed anatomical landmarks, ROIs were then
transferred manually onto PDFF maps at the same ana-
tomical location, and mean PDFF and R2* values were
recorded for each ROI. In controls with mechanical back
pain, freehand ROIs were placed on the largest possible
areas of subchondral bone marrow on both the sacral
and ilial sides of the joint for both the left and right
sacroiliac joints on a single slice. To determine whether
there were statistically significant differences in PDFF
and R2* between areas of normal bone marrow, edema,
and fat metaplasia, data were analyzed using a multi-
level mixed-effects linear regression model on Stata 14.1
(StataCorp, College Station, Texas, USA), which
accounted for repeated observations in individual
patients. Tissue type (i.e., normal marrow, edema, or fat
metaplasia) was used as a predictor variable; PDFF or
R2* were used as outcome variables; and subject number
was included as a grouping variable.
To assess the repeatability of PDFF and R2* measure-
ments, four ROIs (one ROI for each side of the joint, for
both left and right sacroiliac joints) were placed on the
subchondral bone using a single representative slice
through the sacroiliac joints. ROI data were analyzed
using Bland-Altman 95% limits of agreement, with
adjustment of the limits to account for multiple observa-
tions for each individual (43), as well as using the intra-
class correlation coefficient.
FIG. 3. Fat–water and fat–water–bone phantoms. (a) PDFF maps from the fat–water phantom. Labels indicate reference FF values,
which vary between 0 and 100%. (b and (c) PDFF and R2* maps from the fat–water–bone phantom. Reference FF values vary by row,
whereas bone mineral density values vary by column. FF, fat fraction; PDFF, proton density fat fraction.
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RESULTS
Fat–Water and Fat–Water–Bone Phantoms
PDFF maps from the fat–water phantom are shown in
Figure 3a. PDFF and R2* maps from the fat–water–bone
phantom are shown in Figures 3b and 3c.
Figures 4a and 4b show the relationship between
reference FF and measured PDFF values in the fat–water
and fat–water–bone phantoms. In the absence of
bone (Fig. 2a), measured PDFF values agreed closely
with reference FF values (slope¼ 1.036 0.027,
intercept¼ 0.003660.014). Despite the presence of tra-
becular bone, measured PDFF values also agreed closely
with reference FF values in the fat–water–bone phantom
(Fig. 4b). Results of the linear regression analysis are
given in Table 1a.
Figure 4c shows the relationship between trabecular
BMD and measured R2* values, and results of the linear
FIG. 4. Relationship of PDFF and
R2* with reference FF and BMD.
(a) PDFF measurements agree
closely with reference FFs in the
absence of bone. (b) Increases
in bone density have minimal
impact on PDFF measurements
over a physiological BMD range.
(c) R2* measurements are line-
arly related to BMD, although
the slope varies depending on
fat content. (d) Variations in FF
also influence the measured R2*
for a given BMD. BMD, bone
mineral density; FF, fat fraction;
PDFF, proton density fat fraction.
Table 1
Results of Linear Regression Analysis.
A. Measured PDFF Versus Reference Fat Fraction
BMD 0mg/cm3 50mg/cm3 100mg/cm3 150mg/cm3
R2 0.989 0.998 0.991 0.998
Slope 1.036 0.062 1.006 0.026 0.996 0.053 1.0160.029
P¼0.59 P¼0.90 P¼0.85 P¼0.71
Intercept 0.0186 0.025 0.0106 0.011 0.00906 0.021 0.00860.012
P¼0.47 P¼0.34 P¼0.68 P¼0.49
B. Measured R2* Versus Known BMD
Reference FF 0% 20% 40% 50% 60%
R2 0.956 0.985 0.841 0.941 0.997
Slope 0.0005668.5x105 0.000906 7.7105 0.000666 0.00020 0.000806 0.00014 0.00166 6.3  105
Baseline P¼0.39 P¼0.99 P¼0.67 P¼0.002
Intercept 0.02360.0079 0.05560.0072 0.0886 0.019 0.0856 0.013 0.0356 0.0059
Baseline P¼0.27 P¼0.014 P¼0.026 P¼0.88
A. Measured PDFF values agreed closely with known FFs for all BMD values in the phantom.
B. Measured R2* values were linearly related to BMD (all slope values were significantly greater than 0), although the slope varied signif-
icantly depending on the FF. P-values relate to comparison with the 0% FF vial using analysis of covariance.
BMD, bone mineral density; FF, fat fraction; PDFF, proton density fat fraction.
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regression analysis are given in Table 1b. In the absence
of fat, there was a significant linear relationship between
trabecular BMD and R2*. Linear relationships also were
observed in vials containing fat, although slope values
were increased compared to the 0% FF vial. Comparison
of slope values between vials containing fat (i.e.,
between 20%, 40%, 50%, and 60% FFs) revealed no sig-
nificant differences between FFs of 20%, 40%, and 50%;
FIG. 5. PDFF and R2* values in
areas of normal bone marrow,
bone marrow edema, and fat
metaplasia. (a) PDFF values
were significantly increased in
areas of fat metaplasia, and sig-
nificantly reduced in areas of
bone marrow edema compared
to normal subchondral marrow.
(b) R2* values were significantly
reduced in areas of fat metapla-
sia but not significantly altered in
areas of edema. (c) PDFF and
R2* measurements are shown on
a scatterplot; areas of fat meta-
plasia exhibit both increases in
PDFF and reductions in R2*.
BMD, bone mineral density; FF,
fat fraction; PDFF, proton density
fat fraction.
FIG. 6. PDFF maps (a, b) and R2* maps (c, d) demonstrating bone marrow edema and fat metaplasia in patients with sacroiliitis. Bone marrow
edema (a, c; solid red arrow) causes a decrease in PDFF but no change in R2*. Fat metaplasia (b, d; dashed red arrow) causes an increase in
PDFF and a reduction in R2*. The reduction in R2* may indicate a loss of bone mineral density. PDFF, proton density fat fraction.
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however, slope values were significantly increased at
60% FF. Figure 4d shows the relationship between R2*
and reference FF. Although the nature of this relation-
ship was complex, increases in FF at higher bone con-
centrations tended to increase R2* measurements.
Patients and Volunteers
For the patient study, 18 subjects (12 males and 6
females) were prospectively recruited with a mean age of
17 y 5m6 2 y 11m (mean6 standard deviation). Of
these, eight subjects (6 males and 2 females, with mean
age 18 y 2m63 y 4m) had evidence of active or chronic
sacroiliitis using conventional MRI. The remaining 10
subjects (6 males and 4 females, with mean age 16 y
11m62 y 6m) had normal conventional MRI scans and
no clinical or biochemical evidence of sacroiliitis, and
therefore were treated as controls. Images from all sub-
jects were of high quality; there were minor artifacts at
the edges of the field of view in some subjects, but these
did not overlap the pelvis or sacroiliac joints.
PDFF and R2* measurements are compared in normal
marrow, marrow edema, and fat metaplasia in Figure 5.
Example PDFF and R2* maps in patients with active and
chronic sacroiliitis are shown in Figure 6. Median (inter-
quartile range (IQR)) PDFF values were 46.8% (39.5%–
52.5%) in normal bone marrow, 26.9% (21.5–28.2%) in
bone marrow edema, and 82.3% (75.1%–87.8%) in fat
metaplasia. Compared to normal marrow, PDFF measure-
ments were significantly lower in areas of edema
(P¼ 0.047), and were significantly higher in areas of fat
metaplasia (P¼ 0.000). Median (IQR) R2* values were
0.126 ms1 (0.117–0.149 ms1) in normal marrow, 0.112
ms1 (0.102–0136 ms1) in bone marrow edema, and
0.083 ms1 (0.056–0.100 ms1) in fat metaplasia. R2*
was significantly lower in areas of fat metaplasia
(P¼ 0.005), but there was no significant difference in
R2* between normal bone and bone marrow edema
(P¼ 0.461).
Repeatability
For repeatability assessment, eight healthy volunteers
(seven males and one female, mean age 31 y 0m6 3 y
5m) were recruited and scanned on two occasions 1
month apart. After adjusting the limits to account for
FIG. 7. Bland-Altman plots. The figures demonstrate the repeatability of observations for PDFF (a, b) and R2* (c, d) measurements,
using scatterplots (a, c) and Bland-Altman 95% limits of agreement (b, d). Limits were adjusted to account for the presence of multiple
observations for each individual. PDFF, proton density fat fraction.
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multiple observations per individual, Bland Altman 95%
limits of agreement were 1.16 9.9% for PDFF and
0.00056 0.075 ms1 for R2* (Fig. 7). Intraclass correla-
tion coefficients were 0.87 for PDFF and 0.98 for R2*.
DISCUSSION
Here, we present a new approach to the assessment of
active and chronic joint inflammation in spondyloarthri-
tis using CSE-MRI. We show that PDFF measurements
accurately reflect changes in bone marrow composition
in areas of edema and fat metaplasia, which can be
viewed as active inflammatory and structural lesions,
respectively. Additionally, we show that R2* measure-
ments are reduced in areas of fat metaplasia, which may
be due to a reduction in bone mineral density. Inflamma-
tion and structural damage are hallmarks of spondyloar-
thritis, and CSE-MRI could have a multitude of clinical
and research applications in this disease, including mon-
itoring inflammatory activity and structural damage over
time. Although we focused on spondyloarthritis in this
study, it is anticipated that quantitative CSE-MRI could
find utility in other diseases affecting the bone marrow,
such as multiple myeloma or osteomyelitis.
In our fat–water and fat–water–bone phantom experi-
ments, PDFF measurements agreed closely with refer-
ence FF values over a physiologically relevant range,
and essentially were unaffected by variations in BMD. In
patients, PDFF measurements were significantly
decreased in areas of bone marrow edema and were sig-
nificantly increased in areas of fat metaplasia, suggesting
that PDFF is altered at both actively and chronically
inflamed sites. Decreases in PDFF at edematous sites
likely are due to the presence of an inflammatory exu-
date in the juxta-articular marrow (44), whereas increases
in fat content may be due to increases in the proportion
or size of adipocytes in the marrow. Given that fat meta-
plasia is known to be preceded by inflammation (12,15),
our data imply that the bone marrow undergoes biphasic
changes in fat content with inflammation, which can be
directly measured using CSE-MRI.
Our phantom experiments also indicated a positive
association between R2* and BMD (23,45). A number of
authors have previously explored the use of R2* or R2’ as
markers of osteoporosis, and these parameters have been
found to parallel apparent density measured by dual-
energy X-ray absorptiometry (DEXA) or quantitative CT
(QCT) (46–50). However, our results indicate that R2*
measurements also are influenced by PDFF and cannot be
regarded as a pure marker of BMD when fat content varies
as well. Importantly, R2* values also are influenced by
trabecular geometry (51), the assumption of a single sys-
tem R2* decay term for the marrow (30), and the arrange-
ment of the fat and water compartments (52). For
example, in patients with muscular dystrophy, the highest
R2* values occur in muscles where fat and normal muscle
are interdigitated, whereas R2* measurements in patients
with heavily fat-infiltrated muscles are comparable to
those seen in normal subjects (52). Nonetheless, our
results are somewhat different to those observed in
patients with muscular dystrophy in that areas of bone
marrow edema had lower PDFF values than normal
marrow but did not undergo a significant reduction in
R2*. Conversely, there was a significant reduction in R2*
in areas of fat metaplasia. Given the known relationship
between R2* and BMD, this result may be due to a reduc-
tion in trabecular bone mineral density. Previous studies
also support this suggestion. For example, K€uhn et al.
showed that R2* measurements could discriminate nor-
mal and osteoporotic patients with reasonably high levels
of sensitivity and specificity despite concomitant varia-
tions in fat content in osteoporotic individuals (46).
From a biological perspective, reductions in BMD in
areas of fat metaplasia might be expected because inflam-
matory cytokines such as tumor necrosis factor alpha are
known to increase osteoclastic activity (4,53,54). Addi-
tionally, increases in fat content and reduced bone
mineral density in areas of fat metaplasia could occur
through a common mechanism. Previous studies suggest
differentiation of marrow stem cells into adipocytes
occurs at the expense of osteoblasts (55), and it may be
that this balance has been perturbed by previous
inflammation.
There is an extensive literature on the use of qualita-
tive scoring systems to evaluate inflammation of the
sacroiliac joints (11,12,14) but relatively few studies
using quantitative MRI for this purpose. Several small
studies have demonstrated that diffusion-weighted MRI
can be used to quantify inflammation in both adults and
children (56–59), but problems with the reproducibility
of this technique across different scanning platforms and
sites may limit its widespread application (60,61). There
has been very little previous research using CSE-MRI to
evaluate marrow inflammation. A conference abstract by
Lee et al. briefly describes the use of three-point Dixon
MRI to measure changes in FF at vertebral corners in
spondyloarthritis (62), but this work did not utilize R2*
correction or measurement, did not differentiate between
FF changes occurring in acute and chronic inflammation,
and did not involve specific evaluation of the sacroiliac
joints.
As a method for quantifying joint inflammation, the
proposed method has a number of advantages over exist-
ing approaches. Firstly, the repeatability of PDFF and
R2* measurements was excellent, and differences
between repeated measurements were much smaller than
differences between normal bone, edema, and fat meta-
plasia. Intraclass correlation values were similar to previ-
ously quoted values for visual scoring (12). Secondly,
the volumetric nature of the acquisition means that
images can be reformatted in multiple planes without
the need for repeated acquisitions; using conventional
MRI, repeated images are typically acquired in axial,
coronal, and sometimes sagittal planes as well (14).
Therefore, CSE-MRI may help reduce scan time and
could easily be applied to whole body imaging, In addi-
tion, whole body MRI can be used to identify occult
inflammation and facilitate early diagnosis (18,19), and
the method proposed here is likely to be much faster
than existing spin echo-based approaches. Even greater
acceleration could be achieved using compressed sensing
and parallel imaging techniques, as recently described
(63). CSE-MRI also might be used to generate whole
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body R2* maps, which could be applied to monitor
structural damage and progression throughout the spine.
The fat–water–bone phantoms described here provide
a potential framework for refining PDFF and R2* meas-
urements and for evaluating the accuracy of individual
CSE-MRI methods in the bone marrow. Although other
authors have described phantoms in which fat–water
mixtures are used to fill cadaveric human bone (21), the
approach described here allows for direct manipulation
of trabecular bone mineral density using standardized
bone granules and could be replicated easily at other
sites. Fat–water–bone phantoms may be useful because
differences in hardware, sequences, and postprocessing
techniques between imaging platforms could all poten-
tially influence PDFF and R2* measurements. The opti-
mal method is likely to depend on the specific sequence,
imaging platform, image reconstruction software, and
anatomical region. Ideally, it would be possible to com-
pare PDFF and R2* measurements across multiple sites;
further research is required to establish the optimal
imaging method on different platforms and to establish
the reproducibility of these measurements.
A limitation of this study is that the analyses used
here assumed a multipeak fat spectrum that is based on
measurements from human adipose tissue rather than
the bone marrow. However, previous studies suggest that
spectra from bone marrow and human adipose tissue are
extremely similar (42). Additionally, the reference FF
values described in this study do not represent true gold
standard PDFF measurements, which ideally would be
performed using spectroscopy. Nonetheless, reference
FFs and true PDFF values are likely to agree relatively
closely, and the conclusions drawn here are not contin-
gent on precise assessment of accuracy in phantoms. It is
unclear whether the fat spectrum in areas of fat metapla-
sia is altered compared to normal marrow: accurate char-
acterization of the fat spectrum in areas of fat metaplasia
(e.g., using spectroscopy) would help to clarify this
issue. Accurate spectral fat modelling also may help
reduce confounding effects on R2* measurements (25).
Finally, variations in temperature alter the magnitude of
chemical shift between fat and water (64), which was
not accounted for in this study. This may have a small
impact on the phantom experiments, which were per-
formed at room temperature rather than at body
temperature.
The patients included in this study represent a rela-
tively young spondyloarthritis cohort; most subjects
were in their teens. Although imaging may be particu-
larly valuable in this early-onset group (9), changes in
skeletal maturity may influence PDFF and R2* measure-
ments and therefore make quantification of inflammation
more difficult. Younger patients may have more cellular
(i.e., less fatty) marrow and unossified juxta-articular
bone, which may mimic bone marrow edema (65).
Maturity-related changes in marrow composition poten-
tially could be adjusted for using background marrow as
a reference. It also is possible that areas of immature
bone could be differentiated based on their R2* measure-
ments, which would be expected to be lower than those
in fully ossified mature bone. Ultimately, it would be
desirable to develop a technique which could be used to
quantify inflammation across the full age spectrum.
A specific limitation of the fat–water–bone phantom is
that the phantoms were not perfectly homogenous at
high FF and BMD values. PDFF values appeared slightly
higher at the edges of the emulsion, which may be due
to some separation of the oil from the gel. The impact on
absolute PDFF measurements for each vial appeared to
be minimal, although it is likely that this inhomogeneity
had some influence on the measured R2* values, and it
may have contributed to the complex dependence of R2*
on FF. Using either solid animal fats or thick liquid
phantoms, for example, containing carrageenan (31), may
enable construction of more homogenous phantoms with
high FFs. In the future, it would be useful to directly
evaluate the relationship between BMD and R2* in vivo
using DEXA or QCT, although this approach would be
subject to ethical constraints given the use of ionizing
radiation in a cohort of pediatric and young adult
patients.
It should be noted that the bone granules used in this
study only contain the mineral content of trabecular
bone, meaning that the organic matrix is missing and
any effect of collagen on the measured PDFF will not be
present. Experiments with ex-vivo human cortical bone
samples demonstrate that collagen-bound water makes
up a significant fraction (approximately one-third) of the
water content of trabecular bone (66). At the echo times
used for the CSE-MRI in this work, the signal from this
bound-water fraction therefore will be absent due to its
very short T2*. Karampinos et al. have demonstrated
that this can result in overestimation of PDFF in compar-
ison to spectroscopic methods that account for short T2*
water species (67). In the future, using more sophisti-
cated phantoms, including collagen-bound water, may
help overcome this bias.
CONCLUSION
We have shown that PDFF measurements reflect changes
in marrow composition in areas of bone marrow edema
and fat metaplasia and could therefore be used to moni-
tor both active inflammation and structural damage in
spondyloarthritis. R2* measurements may provide addi-
tional information about marrow structure but also are
influenced by fat content. The reduction in R2* in areas
of fat metaplasia is a new finding and may be due to the
loss of trabecular bone mineral density. Furthermore, we
have described a series of fat–water and fat–water–bone
phantoms that provide a potential framework for refine-
ment of PDFF and R2* measurements and evaluation of
the accuracy of individual CSE-MRI methods in the bone
marrow.
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